Genetic assays have transformed how clinicians approach treatment decisions in breast cancer, offering both predictive and prognostic insight that helps tailor therapy to individu ...
A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...
Add Yahoo as a preferred source to see more of our stories on Google. The new risk score could help better manage the follow-up care for patients who've had pancreatic tumors surgically removed, and ...
New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in ...
A risk score based on four factors — male sex, tumor size, World Health Organization (WHO) grade, and lymphovascular invasion — predicts recurrence in patients with node-negative pancreatic ...
Highlights From the 2025 Pediatric Oncology East and Mediterranean Biennial Conference: Advancing Pediatric Oncology Across the Eastern Mediterranean Breast cancer imposes a substantial disease burden ...
A new risk score can help predict whether a pancreatic cancer survivor will suffer a recurrence of cancer The 13-point risk score can help doctors more closely monitor patients at higher risk About 10 ...
The 13-point risk score can help doctors more closely monitor patients at higher risk About 10% of patients suffer a cancer recurrence, most often in their liver FRIDAY, Dec. 19, 2025 (HealthDay News) ...
Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results